Joan Lucca

Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer

David M. Jackman, Beow Y. Yeap, Neal I. Lindeman et al. · Journal of Clinical Oncology · 2007 · 307 citations

Medicine, Oncology, Pharmacology +17

Vaccination With Irradiated Autologous Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor Augments Antitumor Immunity in Some Patients With Metastatic Non–Small-Cell Lung Carcinoma

Ravi Salgia, Thomas J. Lynch, Arthur T. Skarin et al. · Journal of Clinical Oncology · 2003 · 295 citations

Life Sciences, Immunology, Radiation Oncology +14

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study

Pasi A. Jänne, Sarada Gurubhagavatula, Beow Y. Yeap et al. · Lung Cancer · 2004 · 197 citations

Medicine, Oncology, Pharmacotherapy +8

A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer.

Geoffrey I. Shapiro, Jeffrey G. Supko, Angus Patterson et al. · PubMed · 2001 · 174 citations

Medicine, Oncology, Pharmacology +17

A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer.

Panos Fidias, Jeffrey G. Supko, R. Martins et al. · PubMed · 2001 · 111 citations

Medicine, Oncology, Pharmacology +17